A61L 2300/426
Immunomodulating agents, i.e. cytokines, interleukins, interferons
A61L2300/426 (Immunomodulating agents, i.e. cytokines, interleukins, interferons) appears on 322 US grants and 542 published applications in this corpus.
Search patents in A61L- Granted patents
- 322
- Published applications
- 542
- Assignees
- 246
- Inventors
- 881
- Latest grant
- 23 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 3 | 0 |
| 1993 | 1 | 0 |
| 1994 | 8 | 0 |
| 1995 | 4 | 0 |
| 1996 | 4 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 4 | 2 |
| 2002 | 4 | 3 |
| 2003 | 4 | 7 |
| 2004 | 1 | 8 |
| 2005 | 4 | 21 |
| 2006 | 3 | 15 |
| 2007 | 4 | 17 |
| 2008 | 3 | 8 |
| 2009 | 3 | 13 |
| 2010 | 3 | 24 |
| 2011 | 6 | 24 |
| 2012 | 9 | 20 |
| 2013 | 8 | 29 |
| 2014 | 29 | 27 |
| 2015 | 27 | 30 |
| 2016 | 20 | 32 |
| 2017 | 18 | 32 |
| 2018 | 20 | 24 |
| 2019 | 15 | 32 |
| 2020 | 17 | 33 |
| 2021 | 16 | 33 |
| 2022 | 15 | 33 |
| 2023 | 14 | 20 |
| 2024 | 17 | 22 |
| 2025 | 21 | 20 |
| 2026 | 10 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Bioengineered scaffolds for modulation of immune system and the uses thereof23 Jun 2026US 12,661,433 B2President and Fellows of Harvard College
- Tough gel-based drug delivery compositions and methods thereof21 Apr 2026US 12,605,480 B2President and Fellows of Harvard College
- Localized immunosuppression of allografts for peripheral nerve repair14 Apr 2026US 12,599,561 B2University of Wyoming
- Multivalent peptide conjugates for sustained intra-articular treatment of joint inflammation14 Apr 2026US 12,599,663 B2Valitor, Inc.
- Drug delivery system and methods of using the same14 Apr 2026US 12,599,701 B2Axogen Corporation
- Solid forms for tissue repair1 Oct 2026US 2026/0294634 A1Cartiheal (2009) Ltd.
- Porous Polymer Scaffolds, and Methods of Making and Using the Same27 Aug 2026US 2026/0250477 A1The Regents of the University of California
- Drug delivery system and methods of using the same30 Jul 2026US 2026/0216403 A1Axogen Corporation
- Composition and fat grafting using the same9 Jul 2026US 2026/0192018 A1LifeSprout, Inc.
- Tissue-derived compositions with retained bioactive substances and methods for making and using same9 Jul 2026US 2026/0192019 A1Musculoskeletal Transplant Foundation
Most cited
By later US patents
- Drug releasing biodegradable fiber implant1,662US 6,596,296 B1Board of Regents, The University of Texas System · 2003
- Vascular closure device1,319US 8,790,684 B2Cordis Corporation · 2014
- Collagen-polymer conjugates778US 5,162,430 ACollagen Corporation · 1992
- Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor615US 5,328,470 AThe Regents of the University of Michigan · 1994
- Biologically inert, biocompatible-polymer conjugates521US 5,324,775 ACollagen Corporation · 1994